FIELD: chemistry.
SUBSTANCE: present invention relates to novel pyrazole derivatives of formula (I) or pharmaceutically acceptable salts thereof, having tyrosine kinase Trk inhibiting properties and used for treating or preventing malignant growths accompanied by high level of Trk, to a method of producing said derivatives, use thereof to prepare a medicinal agent, pharmaceutical compositions based on said derivatives, a method of inhibiting Trk activity and a method of obtaining antiproliferative action. where A denotes a single bond or C1-2alkylene; where the said C1-2alkylene can be optionally substituted with one R22; ring C is a phenyl or a 5-6-member heterocyclic ring with 1-2 heteroatoms selected from N or S. Values of R1-R7, R22 and n are given in the formula of invention.
EFFECT: obtaining pharmaceutically acceptable salts having tyrosine kinase Trk inhibiting properties and used for treating or preventing malignant growths.
20 cl, 5 dwg, 193 ex
Title | Year | Author | Number |
---|---|---|---|
CHEMICAL COMPOUNDS | 2006 |
|
RU2405780C2 |
CHEMICAL COMPOUNDS-759 | 2008 |
|
RU2481348C2 |
PYRAZOLYLAMINOPYRIDINE DERIVATIVES APPLICABLE AS KINASE INHIBITORS | 2006 |
|
RU2415852C2 |
IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLE[2,3-A]PYRIDINE DERIVATIVES | 2000 |
|
RU2248976C2 |
COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
CHEMICAL COMPOUNDS | 2007 |
|
RU2469034C2 |
POLYCYCLIC AGENTS FOR TREATING RESPIRATORY SYNCYTIAL VIRAL INFECTIONS | 2004 |
|
RU2422444C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
INHIBITOR CONTAINING BICYCLIC DERIVATIVE, METHOD OF PREPARATION AND USE THEREOF | 2020 |
|
RU2820948C2 |
DERIVATIVES OF PYRIMIDINE, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITIONS (VARIANTS) AND INHIBITION METHOD | 2001 |
|
RU2299201C2 |
Authors
Dates
2011-03-10—Published
2004-11-15—Filed